(Q48494720)

12 February 2018

title

Attenuation of the morphine withdrawal syndrome by inhibition of catabolism of endogenous enkephalins in the periaqueductal gray matter (English)

1 reference

16 October 2022

0 references

1 reference

16 October 2022

author name string

R. Maldonado

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1620246

16 October 2022

M. C. Fournié-Zaluski

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1620246

16 October 2022

B. P. Roques

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1620246

16 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1620246

16 October 2022

publication date

1 April 1992

1 reference

12 February 2018

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF00176626.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00176626/fulltext.html

16 October 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF00176626

16 October 2022

1 reference

Naunyn-Schmiedeberg's Archives of Pharmacology

16 October 2022

published in

1 reference

12 February 2018

volume

345

1 reference

12 February 2018

issue

4

1 reference

12 February 2018

page(s)

466-472

1 reference

12 February 2018

Binding in vivo of selective mu and delta opioid receptor agonists: opioid receptor occupancy by endogenous enkephalins

cites work

1 reference

12 December 2020

Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: enkephalin and substance P.

1 reference

12 December 2020

Inhibition of enkephalinase activity attenuates naloxone-precipitated withdrawal symptoms

1 reference

12 December 2020

Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates

1 reference

12 December 2020

Involvement of the locus coeruleus in the potentiation of the quipazine-induced head-twitch response by diazepam and beta-adrenoceptor agonists

1 reference

12 December 2020

A mechanism for the analgesic effect of neurotensin as revealed by behavioral and electrophysiological techniques

1 reference

12 December 2020

Anatomically distinct opiate receptor fields mediate reward and physical dependence

1 reference

12 December 2020

Neutral endopeptidase-24.11 inhibitors: from analgesics to antihypertensives?

1 reference

12 December 2020

Autoradiographic comparison of the distribution of the neutral endopeptidase "enkephalinase" and of mu and delta opioid receptors in rat brain

1 reference

12 December 2020

Bidentate peptides: Highly potent new inhibitors of enkephalin degrading enzymes

1 reference

12 December 2020

The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice

1 reference

12 December 2020

Quantitative method for assessing one symptom of the withdrawal syndrome in mice after chronic morphine administration

1 reference

12 December 2020

Immunohistochemical and subcellular studies of aminopeptidase M localization in rat brain: microvessels and synaptic membranes.

1 reference

12 December 2020

The periaqueductal gray matter mediates opiate-induced immunosuppression

1 reference

12 December 2020

Substance P antagonists and analgesia: a review of the hypothesis

1 reference

12 December 2020

Steroid-protein conjugates. II. Preparation and characterization of conjugates of bovine serum albumin with progesterone, deoxycorticosterone, and estrone

1 reference

12 December 2020

Prevention of degradation of endogenous enkephalins produces inhibition of nociceptive neurones in rat spinal cord

1 reference

12 December 2020

Amelioration of naloxone-precipitated opioid withdrawal symptoms by peripheral administration of the enkephalinase inhibitor acetorphan.

1 reference

12 December 2020

The periaqueductal gray: Site of morphine analgesia and tolerance as shown by 2-way cross tolerance between systemic and intracerebral injections

1 reference

12 December 2020

New kelatorphan-related inhibitors of enkephalin metabolism: improved antinociceptive properties

1 reference

12 December 2020

Sites of action of morphine involved in the development of physical dependence in rats. II. Morphine withdrawal precipitated by application of morphine antagonists into restricted parts of the ventricular system and by microinjection into various br

1 reference

12 December 2020

Activation of periaqueductal grey pools of beta-endorphin by analgetic electrical stimulation in freely moving rats

1 reference

12 December 2020

The antinociceptive effects of SCH-32615, a neutral endopeptidase (enkephalinase) inhibitor, microinjected into the periaqueductal, ventral medulla and amygdala

1 reference

12 December 2020

Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing

1 reference

12 December 2020

Enkephalinase inhibition suppresses naloxone-induced jumping in morphine-dependent mice

1 reference

12 December 2020

Systematic examination in the rat of brain sites sensitive to the direct application of morphine: observation of differential effects within the periaqueductal gray

1 reference

12 December 2020

Stereospecific and Nonstereospecific Effects of (+)- and (—)-Morphine: Evidence for a New Class of Receptors?

1 reference

12 December 2020

Design and evaluation of inhibitors of enkephalin degrading enzymes

1 reference

12 December 2020

Analgesic responses elicited by endogenous enkephalins (protected by mixed peptidase inhibitors) in a variety of morphine-sensitive noxious tests.

1 reference

12 December 2020

Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine

1 reference

12 December 2020

The C-Fragment of β-Lipotropin: An Endogenous Neuroleptic or Antipsychotogen?

1 reference

12 December 2020

Potentiation of enkephalin action by peptidase inhibitors in rat locus ceruleus in vitro

1 reference

12 December 2020

In vivo studies on the enhancement of cholecystokinin release in the rat striatum by dopamine depletion

1 reference

12 December 2020

Differences in physical dependence induced by selective mu or delta opioid agonists and by endogenous enkephalins protected by peptidase inhibitors

1 reference

12 December 2020

Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release of methionine-enkephalin-like material from the rat spinal cord

1 reference

12 December 2020

Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine

1 reference

12 December 2020

Effect of acute morphine treatment on peptide levels in the peri-aqueductal grey

1 reference

12 December 2020

Influence of clonidine on the acute dependence response elicited in naive rats by naloxone

1 reference

12 December 2020

Analgesic activity of substance P following intracerebral administration in rats

1 reference

12 December 2020

Comparison of selective and complete inhibitors of enkephalin-degrading enzymes on morphine withdrawal syndrome

1 reference

12 December 2020

Opiate withdrawal behavior after focal brain stimulation

1 reference

12 December 2020

Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate Analgesia

1 reference

12 December 2020

Analgesia and hyperreactivity produced by intracranial microinjections of morphine into the periaqueductal gray matter of the rat.

1 reference

12 December 2020

A new test for morphine-like physical dependence (addiction liability) in rats

1 reference

12 December 2020

Endopeptidase-24.11 and neuropeptide metabolism

1 reference

12 December 2020

Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes

1 reference

12 December 2020

Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats

1 reference

12 December 2020

Changes in plasma corticosterone levels as a measure of acute dependence upon levorphanol in rats

1 reference

12 December 2020

Enkephalin analogs and physical dependence.

1 reference

12 December 2020

Nociception, enkephalin content and dipeptidyl carboxypeptidase activity in brain of mice treated with exopeptidase inhibitors

1 reference

12 December 2020

Autoradiographic distribution of mu and delta opiate receptors in rat brain using highly selective ligands

1 reference

12 December 2020

In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00176626

1 reference

12 February 2018

1 reference

12 February 2018